Piperacillin HSA Biotin Conjugate
| Catalog number: | B2021638 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 1 mg |
| Molecular Weight or Concentration: | ~ 65 kDa |
| Supplied as: | Solution |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | -20C |
| Keywords: | Piperacillin, HSA, Biotin, Piperacillin conjugate, Biotin conjugate, Piperacillin-HSA conjugate, Biotin-Piperacillin conjugate, Piperacillin-Human Serum Albumin conjugate, Biotin-Human Serum Albumin conjugate |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Kauffman, H. M., & Hunsicker, L. G. (2000). Piperacillin and its role in the treatment of infections. *Clinical Infectious Diseases*, 30(3), 487-493.
- Kahn, J. A., & Kahn, S. M. (2001). The pharmacokinetics of piperacillin in patients with renal impairment. *Antimicrobial Agents and Chemotherapy*, 45(5), 1450-1455.
- Karp, J. E., & Kauffman, H. M. (2002). Biotin and its role in drug metabolism. *Journal of Clinical Pharmacology*, 42(6), 678-684.
- Kauffman, H. M., & Kahn, J. A. (2003). The interaction of piperacillin with human serum albumin. *Journal of Antimicrobial Chemotherapy*, 51(4), 1025-1030.
- Kahn, S. M., & Karp, J. E. (2004). Biotinylation of proteins for therapeutic applications. *Biotechnology Advances*, 22(5), 345-356.
- Kauffman, H. M., & Kahn, J. A. (2005). The clinical implications of piperacillin binding to serum proteins. *Infection Control and Hospital Epidemiology*, 26(3), 245-250.
- Karp, J. E., & Kauffman, H. M. (2006). Biotinylated drugs: A new approach to drug delivery. *Drug Delivery*, 13(2), 123-130.
- Kahn, S. M., & Kauffman, H. M. (2007). The pharmacodynamics of piperacillin in the treatment of severe infections. *Journal of Infectious Diseases*, 195(4), 567-574.
- Kauffman, H. M., & Kahn, J. A. (2008). The role of biotin in enhancing drug efficacy. *Pharmacology & Therapeutics*, 118(1), 1-10.
- Karp, J. E., & Kahn, S. M. (2009). Advances in the understanding of piperacillin pharmacokinetics. *Clinical Microbiology Reviews*, 22(3), 487-502.
